These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34983191)

  • 21. [Statins inhibit inflammatory reaction. CRP advances as a marker of coronary risk].
    MMW Fortschr Med; 2000 Jul; 142(28-29):54-5. PubMed ID: 10959166
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina.
    Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G
    Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin comparisons in controlled clinical trials.
    Citkowitz E
    Am J Cardiol; 2005 Nov; 96(10):1467-8. PubMed ID: 16275204
    [No Abstract]   [Full Text] [Related]  

  • 24. A higher level of IgM anti-oxidized LDL antibodies is associated with a lower severity of coronary atherosclerosis in patients on statins.
    Garrido-Sánchez L; Chinchurreta P; García-Fuentes E; Mora M; Tinahones FJ
    Int J Cardiol; 2010 Nov; 145(2):263-264. PubMed ID: 20004986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein.
    Chan KY; Boucher ES; Gandhi PJ; Silva MA
    Am J Health Syst Pharm; 2004 Aug; 61(16):1676-81. PubMed ID: 15540478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of statins in overall prevention and treatment of coronary artery disease].
    Ye P
    Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(40):2812-4. PubMed ID: 16324332
    [No Abstract]   [Full Text] [Related]  

  • 27. Statin therapy is associated with lower all-cause mortality in patients with non-obstructive coronary artery disease.
    Hwang IC; Jeon JY; Kim Y; Kim HM; Yoon YE; Lee SP; Kim HK; Sohn DW; Sung J; Kim YJ
    Atherosclerosis; 2015 Apr; 239(2):335-42. PubMed ID: 25682032
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use over time of statins in coronary patients in an Italian tertiary referral center.
    Gaspardone A; Proietti I; Altamura L; Tomai F; Versaci F; Crea F; Chiariello L; Gioffrè PA
    Ital Heart J; 2001 Nov; 2(11):848-53. PubMed ID: 11770871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of statin-induced changes in coronary atherosclerosis using intravascular ultrasound with virtual histology.
    Nozue T; Fukui K; Yamamoto S; Kunishima T; Umezawa S; Onishi Y; Tohyama S; Hibi K; Sozu T; Terashima M; Michishita I;
    Coron Artery Dis; 2013 Sep; 24(6):481-6. PubMed ID: 23751736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.
    Iwata A; Miura S; Tanaka T; Ike A; Sugihara M; Nishikawa H; Kawamura A; Saku K
    Coron Artery Dis; 2012 Aug; 23(5):315-21. PubMed ID: 22617341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atherosclerosis or atheroscleritis: what's in a name?
    Simon Ha
    Cardiology; 2002; 98(3):111-2. PubMed ID: 12417807
    [No Abstract]   [Full Text] [Related]  

  • 32. [Correlation of high-sensitivity CRP concentration with the extent of coronary atherosclerosis in men with symptoms of ischemic heart disease].
    Piechota W; Piechota W
    Pol Merkur Lekarski; 2005 May; 18(107):511-5. PubMed ID: 16161944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
    Arbab-Zadeh A
    J Am Coll Cardiol; 2009 Feb; 53(6):528-9; author reply 529. PubMed ID: 19195616
    [No Abstract]   [Full Text] [Related]  

  • 34. Statins and mortality.
    Muntwyler J; Gutzwiller F
    Eur Heart J; 2002 Feb; 23(3):183-4. PubMed ID: 11792128
    [No Abstract]   [Full Text] [Related]  

  • 35. CRP and statins for primary prevention of coronary artery disease.
    Med Lett Drugs Ther; 2008 Dec 15-29; 50(1301-1302):97-8; quiz p following 104. PubMed ID: 19078864
    [No Abstract]   [Full Text] [Related]  

  • 36. [Aggressive statin therapy reduces the progression of atherosclerosis-- DMW15/2005].
    Taut V
    Dtsch Med Wochenschr; 2006 Mar; 131(9):460; author reply 460. PubMed ID: 16493575
    [No Abstract]   [Full Text] [Related]  

  • 37. Of gender, statins, and coronary artery interventions.
    Ferrario CM
    Ther Adv Cardiovasc Dis; 2008 Apr; 2(2):73-4. PubMed ID: 19124409
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of statins on C-reactive protein in patients with coronary artery disease.
    Strandberg TE; Vanhanen H; Tikkanen MJ
    Lancet; 1999 Jan; 353(9147):118-9. PubMed ID: 10023901
    [No Abstract]   [Full Text] [Related]  

  • 39. Statins and regression of coronary atherosclerosis.
    Athyros VG; Kakafika A; Karagiannis A; Mikhailidis DP
    JAMA; 2007 May; 297(20):2197; author reply 2197. PubMed ID: 17519408
    [No Abstract]   [Full Text] [Related]  

  • 40. Percutaneous coronary interventions and statins therapy.
    Nusca A; Melfi R; Di Sciascio G
    Ther Adv Cardiovasc Dis; 2008 Apr; 2(2):101-7. PubMed ID: 19124413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.